New Jersey Statutes Title 26. Health and Vital Statistics 26 § 2H-12.107a

a. As used in this act:

“Long-term care facility” means a facility or distinct part of a facility licensed by the New Jersey Department of Health as a long-term care facility.

“Pharmacist” means a pharmacist licensed pursuant to P.L.2003, c. 280 (C.45:14-40 et seq.).

b. Each long-term care facility shall have a consultant pharmacist and either a provider pharmacist or, if the facility has an in-house pharmacy, a director of pharmaceutical services.

c. A New Jersey-licensed pharmacist shall serve as director of pharmaceutical services or as consultant pharmacist. The pharmacist shall comply with federal and State statutes, rules, regulations, and currently accepted standards of practice.

d. Each long-term care facility shall have an interdisciplinary pharmacy and therapeutics committee, appointed by and reporting to the facility's administrator and consisting of at least the administrator, a representative of the nursing staff, and the facility's consultant pharmacist, with oversight as needed by the facility's medical director.  The committee may include a licensed pharmacist representing the provider pharmacy.  The committee shall hold meetings at least quarterly.  Records, including the dates of meetings, attendance, activities, findings, and recommendations, shall be maintained by the committee.

e. Each long-term care facility shall appoint a consultant pharmacist who is not also the director of pharmaceutical services or pharmacist provider, and who attests that he or she does not have an affiliation with either the facility's director of pharmaceutical services or the facility's pharmacist provider.  Following the appointment of the consultant pharmacist, the consultant pharmacist shall avoid all real or potential conflicts of interest with the facility's director of pharmaceutical services or the facility's pharmacist provider.

f. If a long-term care facility keeps emergency injectable or oral controlled substances, the facility shall ensure that a current Drug Enforcement Administration registration and controlled dangerous substance registration for that location is available.